On 23-24 July 2026, the US Food and Drug Administrations Pharmacy Compounding Advisory Committee recommended that six of seven peptides it assessed (BPC-157, KPV, TB-500,MOTS-c, epitalon and semax) be considered for inclusion on the section 503A Bulks List, potentially permitting their use in patient-specific compounded preparations.[2,7] The votes were close and advisory
they signal repair and adaptation
Interestingly, the cholesterol levels were similar among both groups, showing that theres likely an interaction with visceral fat (or inflammation) and atherosclerosis.[ref] Theres a trend among some health and wellness influencers to minimize the risk of high Lp(a) levels based on a specific study, such as this study showing that visceral fat influences atherosclerosis
Plain language summary Hundreds of millions of people around the world live with rare diseases, but most of these conditions still dont have effective treatments